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Abstract 
The C-terminal domains of the mouse transporter associated with antigen processing (TAP) were expressed as soluble proteins in Drosophila 
melanogaster cells and labeled by [~t-32P]8-azido-ATP after UV-irradiation. The relative potencies of the nucleotides inpreventing azido-ATP labeling 
were in the order ofATP > GTP > CTP > ITP > UTP for both the TAP1 and TAP2 C-terminal domains, uggesting ATP to be the natural substrate 
of the transporter. Our data provide the first evidence that the individual C-terminal domain of either TAP1 or TAP2 can be expressed as a functional 
ATP-binding protein. 
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1. Introduction 
TAP1 and TAP2 are two subunits of  the transporter  
associated with antigen processing (TAP). They are 
MHC-encoded and essential for the antigen presentat ion 
by class I MHC molecules [1-3]. Specifically, TAP trans- 
ports  antigenic peptides from the cytoplasm to the lumen 
of  the endoplasmic ret iculum [4,5], where the peptides 
assemble with the class I MHC heavy chain and fl2- 
microglobul in  before being t ransported to the cell sur- 
face. The hydropathy  profiles of  TAP1 and TAP2 are 
similar, suggesting an N-terminal  hydrophobic  domain  
with possibly six membrane-spanning segments and a 
C-terminal  hydrophi l ic  domain.  The C-terminal  do- 
mains of  TAP1 and TAP2 are highly conserved, with 
about  60% of  their amino acid sequence identical [3]. In 
addit ion,  the TAP C-terminal  domains are highly homol-  
ogous to the nucleot ide-binding domains of  traffic ATP- 
ase or ATP-b inding cassette transporters [6-8]. Walker 
A and Walker  B motifs [9], which are commonly  found 
in the nucleot ide-binding proteins, are also identified in 
the TAP1 and TAP2 C-terminal  domains,  suggesting 
that they may be able to bind nucleotides. 
Experimental ly,  it has been shown that TAP-mediated 
pept ide- t ransport  is ATP-dependent  [4,5]. However, 
questions remain whether ATP molecules interact with 
TAP directly. Discovery of  the nucleot ide-binding prop-  
erties of  the TAP proteins, local izat ion of  the nucleotide- 
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binding sites along the TAP sequences, and i l lumination 
of  the tert iary structures of  the nucleot ide-binding sites 
will certainly provide insight into the mechanism of  the 
ATP-dependent  pept ide-transport  by TAP. In order to 
facil itate the study, we expressed the C-terminal domains 
of  the mouse TAP1 and TAP2 in Drosophila melanogas- 
ter Schneider cells. Since Schneider cells had been used 
to express various mammal ian  proteins quantitat ively in
their functional forms [10], it seemed likely that the C- 
terminal  domains of  TAP1 and TAP2 expressed in 
Schneider cells would be in their native configurations. 
The nucleot ide-binding functions of  the TAP C-terminal  
domains were investigated with photo affinity labeling of  
[32p]8-azido-ATP. The experiments indicate that both the 
TAP1 and TAP2 C-terminal  domains are capable of  
binding ATP with high affinities. The structures and 
functions of  TAP will be discussed. 
2. Materials and methods 
2.1. Construction of the expression vectors 
The cDNA fragments coding for the mouse TAP1 from Gin 445 to 
Asp TM and the mouse TAP2 from Ser 434 to Ala  7°z were isolated from 
their full-length cDNAs [3] using PCR (Polymerase Chain Reaction) 
with Taq polymerase (Perkin Elmer). Both TAPI cDNA and TAP2 
cDNA have been previously cloned into pRMHa3 [11], which will be 
described elsewhere. These plasmids were used as the templates in 
PCRs. For isolating TAP1 C-domain DNA, the primers used in the 
PCR were 5'-AAAGAGCTC ATG (CAC)6 CAG AAG GCT GTG 
GGC TCC T-3', which contains a SacI site followed with the coding 
sequence for Met-(His)6-Gln-Lys-Ala-Val-Gly-Ser, and 5'-GGA- 
GAAGAATGTGAGTGTGCATCGA-Y, which is the sequence of 
pRMHa3 downstream of the TAPI insert. The primers for the TAP2 
C-domain were 5'-TTTCC ATG GTG (CAC)6 AGC AAC GTG GGC 
GCT GCT-3', which contains an NcoI site and the sequence coding for 
Met-Val-(His)6-Ser-Asn-Val-Gly-Ala, and 5'-GTGCATCGAATTGC- 
ATGCCT-3', the sequence of pRMHa3 downstream of the TAP2 in- 
sert. The TAP1 DNA fragment generated from PCR was cut with Sacl 
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and Sail, and the TAP2 DNA fragment was cut with Ncol and Sail. 
They were then ligated into pRMHa3 downstream of the metal- 
lothionein promoter. The complete DNA inserts were sequenced with 
dideoxynucleotide chain termination method on an ABI 373A DNA 
Sequencer (Applied Biosystems, Inc., Foster City, CA). The recombi- 
nant plasmid for TAP1 C-domain expression was named pFHIA, and 
the plasmid for TAP2 C-domain was pFH2A. 
2.2. Protein expression 
22/.tg of pFH 1 A, or pFH2A, was co-transfected with 2/~g phshsneo, 
a selection plasmid [12], into 12 x 10 6 Schneider cells by calcium phos- 
phate method [10]. The transfected cells were cultured in Schneider 
medium (GIBCO/BRL) including 5% fetal bovine serum and 500/tg/ml 
of Geneticin (G418, GIBCO/BRL). The stable transfectants were se- 
lected and maintained inthe presence ofG418 at all time. Expression 
of the domain proteins was induced by adding CuSO 4 into the culture 
medium to the final concentration f 0.7 mM for 24 h. 
2.3. Immuno-blot 
After 24-h induction with CuSO4, about 1000 Schneider cells were 
collected and lysed by suspending in2 x SDS Sample buffer [13] fol- 
lowed by incubation at 95°C for 5 min. The prestained molecular 
weight markers (Bio-Rad) were used to calibrate the molecular masses 
of the proteins of interest. The proteins were separated on a 12.5% 
SDS-polyacrylamide gel and transferred electrophoretically to aBA-S 
85 nitrocellulose filter (Schleicher and Schuell). The blotted filter was 
incubated either with the anti-TAP1 antiserum [3,14] or the anti-TAP2 
antiserum [15,16]. The immunopositive proteins were visualized with an 
alkaline phosphatase-conjugated goat anti-rabbit Ig G (Calbiochem, 
La Jolla, CA). 
2.4. Photo affinity labeling 
After 24-h induction with CuSO4, the Schneider cells were collected, 
washed twice with Dulbecco's phosphate-buffered Saline Solution 
(Irvine Scientific) and then suspended in the ice cold labeling buffer (100 
mM Tris-HC1, pH 7.4, 10 mM MgCI2, 5 mM Na2EDTA, 200 mM 
phenylmethylsulfonyl fluoride, 0.5 /tg/ml leupeptin). Thereafter, the 
process was carried out at below 4°C. The cells were homogenized and 
centrifuged at 100,000 x g for 30 min. The supernatant was equally 
aliquated, for each set of the labeling reactions, into the wells of a 
fiat-bottom 24-well plate. Approximately, 5 x 10 6 cells were used for 
each labeling reaction. The final reaction volume was brought o 400 
/zl with the labeling buffer, including various concentration (0,50, 200, 
500, or 1000/zM) of ATP, GTP, ITP, UTP, or CTP, and 2, or 4/zM 
of [~-nP]8-azido-ATP (ICN, specific activity 8.59 Ci/mmo). ATP, GTP, 
ITP, UTP and CTP were purchased from Sigma s sodium salts. The 
stock solutions of the nucleotides (100 mM) were all adjusted to pH 7.0 
with NaOH and then diluted into the labeling mixtures to the desired 
concentrations. The reaction plate was kept shaking ently in the dark 
for 2 min. The labeling reactions were then started by irradiating the 
reaction mixtures with short-wavelength ultraviolet light from a hand- 
held UV lamp (254 nm, UVSL-25, Ultra-Violet Products, Inc., San 
Diego, CA), which was kept parallel with the plate at 2.5 cm distance. 
During the UV-irradiation, the reaction plate was kept gently rotating 
horizontally. 20 min later, the reactions were stopped by remove the UV 
light and adding 4/tl of 5 mM dithiothreitol into each reaction mixture. 
The domain proteins in the reaction mixtures were immuno-precip- 
itated with either the anti-TAPl antiserum or the anti-TAP2 antiserum. 
The precipitated proteins were dissolve in 2 x SDS sample buffer [13], 
heated at 95°C for 5 min and electrophoretically separated on 10-15% 
SDS-polyacrylamide gradient gels. The gels were fixed, dried and ana- 
lyzed by autoradiography. The extent of radioactive labeling to the 
TAP C-domain proteins on the gels was also quantified by Phosphor- 
Imager Scanner (Molecular Dynamics, Inc. Sunnyvale, CA) and ana- 
lyzed with software ImageQuant (Molecular Dynamics, Inc). 
3. Results 
3.1. Expression o f  the C-terminal domains o f  TAP1 and 
TAP2 
The C-terminal domains of TAP1 and TAP2 are de- 
Walker  A Walker  B 
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Fig. 1. Linear schemes of the C-terminal domains of mouse TAP1 
(C-TAP1) and TAP2 (C-TAP2). The amino acid residues are presented 
with the single-letter amino acid codes. The numbering corresponds to
the amino acid residues in the mouse full-length TAP1 and TAP2 
sequences [3]. The Walker A and Walker B motifs [9] were indicated 
in both C-TAP1 and C-TAP2 by underlining the sequences. The recom- 
binant C-TAPI contains the mouse TAPI sequence from Q445 to D724 
and C-TAP2 contains the mouse TAP2 from $434 to A702. Secondary 
structure prediction with the Chou-Fasman algorithm suggests a typi- 
cal nucleotide-binding folding, alternating fl-strands and 0~-helices [18], 
located in TAP1 (between amino acids 490 and 690) and TAP2 (be- 
tween amino acids 480 and 680). 
fined based on the hydropathy analyses of the amino 
acid sequences [3]. For mouse TAP1, the C-terminal do- 
main starts from Gln 445, and for mouse TAP2, at Ser 434 
(Fig. 1). These C-terminal domains have high degrees of 
sequence homology to the nucleotide-binding domains 
of traffic ATPase or ATP-binding cassette transporters 
[17] and contain the sequence of about 200 amino acid 
residues where the predicted secondary structures are 
typical of a nucleotide-binding fold [18]. In addition, 
Walker A and Walker B motifs [9], found in many nu- 
cleotide-binding proteins, were also identified in these 
domains (Fig. 1). It is, therefore, hypothesized that each 
C-terminal domain of TAP forms a nucleotide-binding 
domain. In order to test this hypothesis, the DNA frag- 
ments coding for the entire mouse TAP1 and TAP2 
C-terminal domains (Fig. 1) were inserted into an expres- 
sion plasmid, pRMHa3 [11] and transfected into Droso- 
phila melanogaster cells. The expression of the TAP 
C-terminal domains was under the control of a metal- 
lothionein promoter and can be induced by Cu 2÷. 
The expression of the recombinant TAP1 and TAP2 
C-terminal domains was detected with immuno-blott ing.  
As shown in Fig. 2, two proteins from the cells trans- 
fected with the TAP1 C-terminal domain expression 
plasmid were found positive to the anti-TAP1 antiserum 
and were labeled as C-TAP 1 ( -  31 kDa) and sC-TAP1 ( -  27 
kDa). These two proteins were not found in the Schnei- 
der cells either not transfected or transfected only with 
the TAP2 C-terminal domain expression plasmid (data 
not shown). When the lysate prepared from the TAP1 
C-terminal domain transfectants was applied on to a 
Ni -NTA agarose column [19], only the 31-kDa C-TAP1 
protein was retained by the column, while the 27-kDa 
sC-TAP1 protein was washed out of the column without 
binding (data not shown). This suggests that the (His)6- 
tag at the N-terminus of the recombinant TAP1 C-do- 
main (see section 2) is intact in the 31-kDa C-TAP1 
protein, but missed from the 27-kDa sC-TAP1 protein. 
By examining the TAP1 cDNA sequence, it is concluded 
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that both the proteins were derived from the TAP1 C- 
terminal domain DNA construct. The C-TAP1 protein 
was translated from the first initiation codon, while the 
sC-TAP1 protein was translated from an internal 
methionine codon, corresponding to Met 475 of  mouse 
TAP1 sequence [3]. Compared to the TAP1 C-terminal 
domain transfectants, only one immuno-positive pro- 
tein, labeled as C-TAP2 in Fig. 2, was identified in the 
TAP2 C-terminal domain transfectants by the anti- 
TAP2 antiserum. This protein was not detected in the 
untransfected Schneider cells and the TAP1 C-terminal 
domain transfectants. The size of  the protein is about 30 
kDa on the immuno-blot,  and comparable to the size 
predicted from the amino acid sequence of  the recombi- 
nant TAP2 C-terminal domain protein. The recombi- 
nant C-terminal domain proteins of  TAP1 and TAP2 
were expressed in the cytoplasm of  the Schneider cells, 
which was confirmed with immuno-fluorescent staining 
(data not shown). In agreement with the physical nature 
of  their amino acid sequences, the recombinant C-termi- 
nal domain proteins were found to be water soluble. The 
yields of  C-TAP1 and C-TAP2 proteins were estimated 
to be around 2 mg per liter. 
3.2. Az ido-ATP labeling of  the proteins 
It is very likely that these soluble C-terminal domain 
proteins retain their native tertiary structures, because 
Blue-sepharose, a resin that binds many nucleotide-bind- 
ing proteins [20], retained the C-terminal domain pro- 
teins (data not shown), indicating possible nucleotide- 
binding functions of  the recombinant proteins expressed 
in the Schneider cells. To investigate this possibility, 
photo affinity labeling with [32p]8-azido-ATP, a method 
that has been used widely in studying various ATP-bind- 
ing proteins, including many members in the traffic 
ATPase transporter superfamily [21-24], was used here. 
Proteins in the supernatant fractions prepared from 
1 2 3 4 
kDa 
kDa 
kDa 
kDa 
Fig. 2. Expression of the Recombinant C-terminal Domains of TAP1 
and TAP2. Proteins from Schneider cells transfected with no plasmid 
(lane 1 and 3), or with plasmid pFHIA (lane 2), or pFH2A (lane 4), 
were immuno-blotted with either the anti-TAP1 antiserum (lane 1 and 
2), or the anti-TAP2 antiserum (lane 3 and 4). The expressed recombi- 
nant proteins are indicated on the left side of the figure as C-TAPI, 
sC-TAP1 and C-TAP2. On the right side, protein standards are local- 
ized and expressed in kilodalton (kDa). 
Fig. 3. Photo Affinity Labeling of the TAP C-terminal Domain Proteins 
with 8-Azido-ATP. Proteins from the Schneider cells transfected with 
pFH1A (A), or pFH2A (B) were labeled with [¢z-32P]8-azido-ATP as 
described in section 2. The labeling reaction was carried out in the 
absence (lane 1), or presence of 1 mM ATP (lane 2), GTP (lane 3), ITP 
(lane 4), UTP (lane 5), or CTP (lane 6). The proteins were immuno- 
precipitated either with the anti-TAPl antiserum (A) or anti-TAP2 
antiserum (B). The radioactive bands corresponding to the recombi- 
nant TAP C-domain proteins were marked on the left side of the figure. 
It seems that in the presence of 1 mM CTP (lane 6), sC-TAP1 and 
C-TAP2 were not radioactively labeled. However, prolonged exposure 
of the gel revealed some labeling to sC-TAP1 and C-TAP2 in the 
presence of 1 mM CTP. A very low density band is visible in the lane 
2 (A). It is believed that the radioactivity found in the lane 2 is from 
the lane 1, since in other experiments, he labeling to C-TAP1 was 
completely blocked by ATP at 500 mM, e.g. the experiment described 
in Fig. 4. 
the transfectant homogenates were UV irradiated in the 
presence of  2 pM [32P]8-azido-ATP and immuno-precip- 
itated with either the anti-TAP1 antiserum or the anti- 
TAP2 antiserum. The immuno-precipitates were ana- 
lyzed by SDS-polyacrylamide g l electrophoresis and the 
labeling to the proteins was visualized by autoradiogra- 
phy. Two radioactive bands with the expected molecular 
masses for C-TAP1 and sC-TAP1 were detected in the 
C-TAP1 transfectants (Fig. 3, panel A, lane 1), and one 
with the size of  C-TAP2 was detected in the C-TAP2 
transfectants (Fig. 3, panel B, lane 1). These three bands 
were only found in the transfectants that had been in- 
duced with CuSO4, but not in the non-induced transfec- 
tants (data not shown). The labeled proteins were further 
eluted from the dried gel slices and analyzed with im- 
muno-blott ing to confirm their identities. The two la- 
beled proteins from the C-TAP1 transfectants were rec- 
ognized by the anti-TAP1 antiserum, and the labeled 
30-kDa protein from the C-TAP2 transfectants was rec- 
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Fig. 4. Inhibition of the 8-Azido-ATP labeling to the C-TAP] Protein 
(A) and the C-TAP2 Protein (B) by Nucleotides. Proteins were labeled 
with [cz-~2P]8-azido-ATP (4/ IM) in the presence of a various concentra- 
tion (0, 50, 200, or 500/zM) of ATP (diamonds), GTP (squares), or ITP 
(triangles) as described in section 2. The radioactivity associated with 
the C-TAP] and C-TAP2 on SDS-po]yacrylamide gels was quantified 
by Phosphor-lmager Scanner and presented here on the Y-axes as the 
percentage labeling. 
ognized by the anti-TAP2 antiserum (data not shown), 
which support that these three labeled proteins are in- 
deed the recombinant TAP C-terminal domain proteins. 
Under the same experimental conditions, the intact 
TAP1 and TAP2 from RMA cells were also labeled by 
[32p]8-azido-ATP (data not shown). 
When 1 mM ATE or GTP, was included in the label- 
ing reaction mixtures, the labeling to the recombinant 
C-TAP1, sC-TAP1 and C-TAP2 proteins was almost 
completely blocked (Fig. 3, lanes 2 and 3), whereas in the 
presence of 1 mM ITP, UTP, or CTP, the labeling to the 
proteins was only partially inhibited (lanes 4, 5 and 6 of 
Fig. 3). The findings that the labeling to the domain 
proteins occurred at a micromolar concentration of 8- 
azido-ATP (2/~M), and ATP and GTP can efficiently 
inhibit the labeling suggest hat 8-azido-ATP was tar- 
geted to the nucleotide-binding sites of the proteins. It 
was concluded that the recombinant TAP1 and TAP2 
C-terminal domain proteins expressed in Drosophila cells 
retain the nucleotide-binding sites and these sites have 
higher affinities for ATP and GTP than for ITP, CTE 
and UTE 
3.3. The nucleotide binding specificity of the TAP 
C-terminal domains 
A similar pattern of the labeling inhibition by the nu- 
cleotides was observed for the TAP1 and TAP2 C-termi- 
nal domains. It seems that ATP and GTP are the most 
potent inhibitors, CTP and ITP the second, and UTP the 
least potent inhibitor. However, it was not clear whether 
both the TAP1 and TAP2 nucleotide-binding sites prefer 
ATP over GTP, or GTP over ATE or one site prefers 
ATP while the other prefers GTP. To further delineate 
the nucleotide specificity of the nucleotide-binding site 
within each TAP C-terminal domain, the labeling reac- 
tion was carried out in the presence of a various concen- 
tration (0, 50, 200, or 500/IM) of ATP, GTP, or ITP. The 
extent of the labeling to each domain protein was quan- 
tified and compared with the labeling of the same protein 
without any inhibitory nucleotide added to the reaction. 
The data were summarized in Fig. 4. For both TAP1 and 
TAP2 C-terminal domain proteins, ATP is the most po- 
tent inhibitor of the labeling among the nucleotides 
tested, with the 50% inhibition of the labeling at about 
40 to 50/~M of ATE whereas, the 50% inhibition was 
achieved by GTP at about 200/~M. In comparison with 
ATP and GTP, ITP is not efficient in preventing the 
domain proteins from labeling by 8-azido-ATP. In sum- 
mary, the relative potencies of the nucleotides in block- 
ing azido-ATP labeling to the recombinant TAP1 and 
TAP2 C-terminal domain proteins were in the order of 
ATP > GTP > CTP > ITP > UTP. Assuming that the 
inhibitory nucleotides compete with 8-azido-ATP at the 
same nucleotide-binding site within each domain pro- 
tein, the potency of the nucleotides in preventing the 
labeling should correlate with their affinity for the nucle- 
otide-binding site of the protein. The data indicate that 
ATP binds to both TAP1 and TAP2 nucleotide-binding 
sites with the highest affinity, suggesting that ATP is the 
natural igand, or the substrate for TAP1 and TAP2. 
4. Discussion 
It is concluded from this study that both TAP1 and 
TAP2 contain an ATP-binding site within their C-termi- 
nal domains. Although their sequences are not identical, 
the two C-terminal domains were found to have a same 
nucleotide-binding specificity. This nucleotide specificity 
was also observed in other traffic ATPase transporters, 
such as MalK protein [21,23] and P glycoprotein [22], 
suggesting similarities in their tertiary structures. How- 
ever, the TAP1 and TAP2 C-terminal domains might 
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have functional differences. They might alternately bind 
and hydrolyze ATP molecules in the catalytic ycle of the 
functional TAP1 and TAP2 heterodimer. Alternatively, 
the two C-terminal domains might regulate the peptide- 
transport function of TAP differently through their con- 
formational changes during the ATP-binding and hy- 
drolysis, the phosphorylation f their residues by protein 
kinases or by interacting with other ER membrane pro- 
teins and the proteins from the cytosol, such as chaper- 
one proteins (Y.Y. and P.A.P., unpublished ata). 
A common tertiary structural model has been pro- 
posed for the ATP-binding domains in the traffic ATP- 
ase transporter superfamily [25]. However, crystal struc- 
tural information has not been obtained for any of the 
ATP-binding domains of the traffic ATPase trans- 
porters. The intact TAP proteins expressed in Schneider 
cells were found to transport peptides in an ATP-de- 
pendent manner (data not shown), indicating the TAP1 
and TAP2 are functional, but their expression levels were 
very low comparing to that of the C-terminal domain 
proteins. The low expression levels of intact TAP pro- 
teins are likely due to their ER membrane localization as 
indicated by immuno-fluorescent staining (data not 
shown). We have attempted to purify the intact TAP 
proteins from Schneider cells, but it has been difficult to 
purify the intact TAP proteins. In contrast, the TAP 
C-terminal domains were expressed as soluble proteins 
quantitatively (about 2 mg per liter) in Schneider cells 
and their purification would be much easier. Recently, 
the TAP C-terminal proteins have been purified by 
chromatography (data not shown) to the quantities suffi- 
cient for the X-ray crystallography and NMR study. 
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